Viridian Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US92790C1045
USD
32.46
2.03 (6.67%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
671.64
442.02
395.06
187.72
120.04
15.75
Shareholder's Funds
671.64
442.02
395.06
187.72
120.04
15.75
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
21.10
21.05
5.26
0.52
0.46
8.30
Secured Loans
21.10
21.05
5.26
0.52
0.46
8.30
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
2.31
1.56
2.03
2.36
0.54
0
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
22.89
21.77
6.68
2.36
0.54
4.33
Current Liabilities
Trade Payables
2.14
2.24
14.23
2.33
0.67
1.10
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
47.87
26.64
33.35
13.64
10.67
10.18
Total Liabilities
742.40
490.42
435.09
203.71
131.25
30.26
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
4.71
4.39
4.94
3.83
4.23
3.87
Less: Accumulated Depreciation
1.27
1.05
2.00
1.78
3.44
3.35
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
3.44
3.34
2.94
2.06
0.79
0.52
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.50
0.60
0.98
1.49
0.86
0.00
Total Non-Current Assets
3.94
3.95
3.92
3.55
1.64
0.52
Current Assets Loans & Advances
Current Investments
617.99
374.54
268.97
154.67
81.74
2.00
Inventories
0.00
0.00
0.00
0.00
0.00
0.00
Sundry Debtors
0.00
0.10
0.10
0.45
0.00
0.11
Cash and Bank
99.59
102.83
155.58
42.30
45.90
24.85
Other Current Assets
717.58
477.47
424.65
197.42
127.64
26.95
Short Term Loans and Advances
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Assets
738.46
486.48
431.17
200.16
129.61
29.74
Net Current Assets (Including Current Investments)
690.59
459.84
397.82
186.53
118.94
19.56
Total Current Assets Excluding Current Investments
738.46
486.48
431.17
200.16
129.61
29.74
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
742.40
490.42
435.09
203.71
131.25
30.26
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
21.10
21.05
5.26
0.52
0.46
8.30
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Dec 2024 is 1.88% vs 335.34% in Dec 2023

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2024 is 48.08% vs -23.15% in Dec 2023

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2024 is 2.99% vs 13.61% in Dec 2023

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Dec 2024 is 51.80% vs 12.83% in Dec 2023

Compare Balance Sheet Results of Viridian Therapeutics, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
671.64
-109.27
780.91
714.66%
Shareholder's Funds
671.64
-109.27
780.91
714.66%
Minority Interest
0
64.73
-64.73
-100.00%
Long-Term Borrowings
21.10
2,502.05
-2,480.95
-99.16%
Secured Loans
21.10
2,502.05
-2,480.95
-99.16%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0
0.00
0.00%
Other Long Term Liabilities
2.31
254.42
-252.11
-99.09%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
1.25
-1.25
-100.00%
Total Non-Current Liabilities
22.89
2,416.21
-2,393.32
-99.05%
Current Liabilities
Trade Payables
2.14
258.69
-256.55
-99.17%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
1.25
-1.25
-100.00%
Total Current Liabilities
47.87
1,129.77
-1,081.90
-95.76%
Total Liabilities
742.40
3,501.45
-2,759.05
-78.80%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
4.71
1,087.21
-1,082.50
-99.57%
Less: Accumulated Depreciation
1.27
563.52
-562.25
-99.77%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
3.44
523.69
-520.25
-99.34%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
0
35.92
-35.92
-100.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
0.50
9.03
-8.53
-94.46%
Total Non-Current Assets
3.94
1,913.64
-1,909.70
-99.79%
Current Assets Loans & Advances
Current Investments
617.99
0
617.99
0.00%
Inventories
0
612.45
-612.45
-100.00%
Sundry Debtors
0
775.73
-775.73
-100.00%
Cash and Bank
99.59
118.42
-18.83
-15.90%
Other Current Assets
717.58
1,539.44
-821.86
-53.39%
Short Term Loans and Advances
0
32.83
-32.83
-100.00%
Total Current Assets
738.46
1,587.81
-849.35
-53.49%
Net Current Assets (Including Current Investments)
690.59
458.04
232.55
50.77%
Total Current Assets Excluding Current Investments
738.46
1,587.81
-849.35
-53.49%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
742.40
3,501.45
-2,759.05
-78.80%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
21.10
2,502.05
-2,480.95
-99.16%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 20.58 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 1.88% vs 335.34% in Dec 2023

Annual - Other Long Term Liabilities
Other Long Term Liabilities 2.31 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 48.08% vs -23.15% in Dec 2023

Annual - Fixed Assets
Fixed Assets 3.44 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 2.99% vs 13.61% in Dec 2023

Annual - Investments
Markets Mojo
No Investments in the last few periods
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 738.46 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 51.80% vs 12.83% in Dec 2023